Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

An augmented volume-based model of the glass transition temperature of 209 molecular liquids.

Preiss UP, Saleh MI.

J Pharm Sci. 2013 Jun;102(6):1970-80. doi: 10.1002/jps.23553. Epub 2013 Apr 17.

PMID:
23595896
2.

Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.

Kawakami K, Usui T, Hattori M.

J Pharm Sci. 2012 Sep;101(9):3239-48. doi: 10.1002/jps.23166. Epub 2012 Apr 24.

PMID:
22531946
3.

An investigation into the influence of counterion on the properties of some amorphous organic salts.

Towler CS, Li T, Wikström H, Remick DM, Sanchez-Felix MV, Taylor LS.

Mol Pharm. 2008 Nov-Dec;5(6):946-55. doi: 10.1021/mp8000342.

PMID:
19434850
4.

Correlation between glass-forming ability and fragility of pharmaceutical compounds.

Kawakami K, Harada T, Yoshihashi Y, Yonemochi E, Terada K, Moriyama H.

J Phys Chem B. 2015 Apr 9;119(14):4873-80. doi: 10.1021/jp509646z. Epub 2015 Mar 25.

PMID:
25781503
5.

Early drug development predictions of glass-forming ability and physical stability of drugs.

Mahlin D, Bergström CA.

Eur J Pharm Sci. 2013 May 13;49(2):323-32. doi: 10.1016/j.ejps.2013.03.016. Epub 2013 Apr 2.

6.

A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.

Kalogeras IM.

Eur J Pharm Sci. 2011 Apr 18;42(5):470-83. doi: 10.1016/j.ejps.2011.02.003. Epub 2011 Feb 13.

PMID:
21324354
7.

Computational approach for fast screening of small molecular candidates to inhibit crystallization in amorphous drugs.

Pajula K, Lehto VP, Ketolainen J, Korhonen O.

Mol Pharm. 2012 Oct 1;9(10):2844-55. Epub 2012 Aug 27.

PMID:
22867030
8.

Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.

Alie J, Menegotto J, Cardon P, Duplaa H, Caron A, Lacabanne C, Bauer M.

J Pharm Sci. 2004 Jan;93(1):218-33.

PMID:
14648651
9.

Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.

Trasi NS, Baird JA, Kestur US, Taylor LS.

J Phys Chem B. 2014 Aug 21;118(33):9974-82. doi: 10.1021/jp504450h. Epub 2014 Aug 7.

PMID:
25076138
10.

Structural signature of slow dynamics and dynamic heterogeneity in two-dimensional colloidal liquids: glassy structural order.

Kawasaki T, Tanaka H.

J Phys Condens Matter. 2011 May 18;23(19):194121. doi: 10.1088/0953-8984/23/19/194121. Epub 2011 Apr 27.

PMID:
21525551
11.
12.

Solid state amorphization of pharmaceuticals.

Willart JF, Descamps M.

Mol Pharm. 2008 Nov-Dec;5(6):905-20. doi: 10.1021/mp800092t. Review.

PMID:
18954076
13.

Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation.

Amharar Y, Curtin V, Gallagher KH, Healy AM.

Int J Pharm. 2014 Sep 10;472(1-2):241-7. doi: 10.1016/j.ijpharm.2014.06.038. Epub 2014 Jun 23.

PMID:
24968139
14.

An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.

Qi S, Weuts I, De Cort S, Stokbroekx S, Leemans R, Reading M, Belton P, Craig DQ.

J Pharm Sci. 2010 Jan;99(1):196-208. doi: 10.1002/jps.21811.

PMID:
19492312
15.

Theoretical Considerations of the Prigogine-Defay Ratio with Regard to the Glass-Forming Ability of Drugs from Undercooled Melts.

Wyttenbach N, Kirchmeyer W, Alsenz J, Kuentz M.

Mol Pharm. 2016 Jan 4;13(1):241-50. doi: 10.1021/acs.molpharmaceut.5b00688. Epub 2015 Dec 10.

PMID:
26587865
16.

Experimental and computational prediction of glass transition temperature of drugs.

Alzghoul A, Alhalaweh A, Mahlin D, Bergström CA.

J Chem Inf Model. 2014 Dec 22;54(12):3396-403. doi: 10.1021/ci5004834. Epub 2014 Dec 1.

PMID:
25361075
17.

Effect of counterions on the properties of amorphous atorvastatin salts.

Sonje VM, Kumar L, Puri V, Kohli G, Kaushal AM, Bansal AK.

Eur J Pharm Sci. 2011 Nov 20;44(4):462-70. doi: 10.1016/j.ejps.2011.08.023. Epub 2011 Sep 1.

PMID:
21907794
18.

Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.

Hancock BC, Shamblin SL, Zografi G.

Pharm Res. 1995 Jun;12(6):799-806.

PMID:
7667182
19.

Glass transition temperature and its relevance in food processing.

Roos YH.

Annu Rev Food Sci Technol. 2010;1:469-96. doi: 10.1146/annurev.food.102308.124139. Review.

PMID:
22129345
20.

Stabilization of amorphous paracetamol based systems using traditional and novel strategies.

Martínez LM, Videa M, López-Silva GA, de Los Reyes CA, Cruz-Angeles J, González N.

Int J Pharm. 2014 Dec 30;477(1-2):294-305. doi: 10.1016/j.ijpharm.2014.10.021. Epub 2014 Oct 19.

PMID:
25447825

Supplemental Content

Support Center